Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer

Clinical Breast Cancer

Volumn 11, Issue 4, 2011, Pages 221-227

  Lustberg, Maryam B ^a   Povoski, Stephen P ^a   Zhao, Weiqiang ^a   Ziegler, Rebecca M ^a   Sugimoto, Yasuro ^b   Ruppert, Amy S ^b   Lehman, Amy M ^b   Shiels, Donna R ^c   Mrozek, Ewa ^a   Ramaswamy, Bhuvaneswari ^a   Layman, Rachel M ^a   Brueggemeier, Robert W ^b   Shapiro, Charles L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Celecoxib; COX 2 inhibitor; Estrogen receptor; Exemestane; Ki 67; Neoadjuvant

Indexed keywords

AROMATASE; CELECOXIB; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; EXEMESTANE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ARTHRALGIA; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DRUG TOLERABILITY; DRUG WITHDRAWAL; EARLY CANCER; EDEMA; FATIGUE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEARTBURN; HOT FLUSH; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; MYALGIA; NAUSEA; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE; RASH; SENSORY NEUROPATHY; TISSUE MICROARRAY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 80052711291     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2011.03.022     Document Type: Article

References (22)

1. I.E. Smith, M. Dowsett, and S.R. Ebbs Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial J Clin Oncol 23 2005 5108 5116 (Pubitemid 46224019)
2. L. Cataliotti, A.U. Buzdar, and S. Noguchi Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial Cancer 106 2006 2095 2103 (Pubitemid 43673229)
3. W. Eiermann, S. Paepke, and J. Appfelstaedt Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study Ann Oncol 12 2001 1527 1532 (Pubitemid 34065880)
4. V.F. Semiglazov, V.V. Semiglazov, and G.A. Dashyan Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer Cancer 110 2007 244 254 (Pubitemid 47121883)
5. G. Mustacchi, M. Mansutti, and C. Sacco Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study Ann Oncol 20 2009 655 659
6. L.W. Chow, A.Y. Yip, and W.T. Loo Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer J Steroid Biochem Mol Biol 111 2008 13 17
7. J.M. Dixon, C.D. Love, and C.O. Bellamy Letrozole as primary medical therapy for locally advanced and large operable breast cancer Breast Cancer Res Treat 66 2001 191 199 (Pubitemid 32675021)
8. H. Sasano, and N. Harada Intratumoral aromatase in human breast, endometrial, and ovarian malignancies Endocr Rev 19 1998 593 607 (Pubitemid 28467713)
9. W.R. Miller, P. Mullen, and P. Sourdaine Regulation of aromatase activity within the breast J Steroid Biochem Mol Biol 61 1997 193 202 (Pubitemid 27455678)
10. E. Diaz-Cruz, C.L. Shapiro, and R.W. Brueggemeier Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells J Clin Endo Met 90 2005 2563 2570 (Pubitemid 40686292)
11. A. Badawi, and M.Z. Badr Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma and levels of prostaglandin E2 Int J Cancer 103 2003 84 90
12. R. Brueggemeier, A.L. Quinn, and M.L. Parrett Correlation of aromastase and cyclooxygenase gene expression in human breast cancer specimens Cancer Lett 140 1999 27 35 (Pubitemid 29251310)
13. E. Pesenti, J. Masferrer, and E. di Salle Effect of exemestane and celecoxib alone or in combination on DBMA-induced mammary carcionma in rats Breast Cancer Res 69 2001 288 (Pubitemid 33789160)
14. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672 2685 (Pubitemid 28363030)
15. D.C. Allred, J.M. Harvey, and M. Berardo Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168 (Pubitemid 28144151)
16. P.A. Canney, M.A. Machin, and J. Curto A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer Eur J Cancer 42 2006 2751 2756 (Pubitemid 44584673)
17. C. Falandry, M. Debled, and T. Bachelot Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study Breast Cancer Res Treat 116 2009 501 508
18. L.A. Martin, G.L. Davies, and M.T. Weigel Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer Breast Cancer Res Treat 123 2010 829 836
19. Bundred NJ, Cramer A, Morris J, et al. Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial. Clin Cancer Res 16:1605-12.
20. Y. Zhao, V.R. Agarwal, and C.R. Mendelson Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 1996 5739 5742 (Pubitemid 26423150)
21. S.D. Solomon, J. Wittes, and P.V. Finn Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Circulation 117 2008 2104 2113 (Pubitemid 351572169)
22. S.D. Solomon, J.J. McMurray, and M.A. Pfeffer Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 352 2005 1071 1080 (Pubitemid 40365348)